Delivery of RNA interference

被引:163
|
作者
Li, Charles X. [1 ]
Parker, Amy [1 ]
Menocal, Ellen [1 ]
Xiang, Shuanglin [1 ]
Borodyansky, Laura [1 ]
Fruehauf, Johannes H. [1 ]
机构
[1] Harvard Univ, Sch Med, Div Gastroenterol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
RNA interference; gene therapy; gene delivery; therapeutic RNAi; transkingdom RNA interference;
D O I
10.4161/cc.5.18.3192
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over the last few years, RNA Interference (RNAi), a naturally occurring mechanism of gene regulation conserved in plant and mammalian cells, has opened numerous novel opportunities for basic research across the field of biology. While RNAi has helped accelerate discovery and understanding of gene functions, it also has great potential as a therapeutic and potentially prophylactic modality. Challenging diseases failing conventional therapeutics could become treatable by specific silencing of key pathogenic genes. More specifically, therapeutic targets previously deemed "undruggable" by small molecules, are now coming within reach of RNAi based therapy. For RNAi to be effective and elicit gene silencing response, the double-stranded RNA molecules must be delivered to the target cell. Unfortunately, delivery of these RNA duplexes has been challenging, halting rapid development of RNAi-based therapies. In this review we present current advancements in the field of siRNA delivery methods, including the pros and cons of each method.
引用
收藏
页码:2103 / 2109
页数:7
相关论文
共 50 条
  • [1] Polyethylenimine and chitosan carriers for the delivery of RNA interference effectors
    Molinaro, Roberto
    Wolfram, Joy
    Federico, Cinzia
    Cilurzo, Felisa
    Di Marzio, Luisa
    Ventura, Cinzia A.
    Carafa, Maria
    Celia, Christian
    Fresta, Massimo
    EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (12) : 1653 - 1668
  • [2] RNA-interference effectors and their delivery
    Doody, A.
    Putnam, D.
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2006, 23 (02): : 137 - 164
  • [3] RNA interference technology with emphasis on delivery vehicles-prospects and limitations
    Prabha, Shashi
    Vyas, Ruchi
    Gupta, Nidhi
    Ahmed, Bahar
    Chandra, Ramesh
    Nimesh, Surendra
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2016, 44 (06) : 1391 - 1399
  • [4] Delivery of RNA interference therapeutics using polycation-based nanoparticles
    Howard, Kenneth Alan
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (09) : 710 - 720
  • [5] Hepatic RNA interference: delivery by synthetic vectors
    Haynes, Matthew T.
    Huang, Leaf
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2014, 4 (01) : 61 - 73
  • [6] Transkingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA
    Aigner, Achim
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (12) : 1533 - 1542
  • [7] Application of Carbon Nanomaterials in Gene Delivery for Endogenous RNA Interference In Vitro and In Vivo
    Li, Lanying
    Wen, Yanli
    Xu, Qin
    Xu, Li
    Liu, Dong
    Liu, Gang
    Huang, Qing
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (22) : 3191 - 3198
  • [8] Delivery strategies: RNA interference in agriculture and human health
    Heidebrecht, Richard W., Jr.
    PEST MANAGEMENT SCIENCE, 2017, 73 (04) : 686 - 691
  • [9] RNA interference in immune cells by use of osmotic delivery of siRNA
    Aoki, M
    Ishii, T
    Kanaoka, M
    Kimura, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (02) : 326 - 333
  • [10] Proof of RNA Interference in Humans after Systemic Delivery of siRNAs
    Kurreck, Jens
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (36) : 6258 - 6259